Correlations Between Gut Microbiome Changes, Gut Barrier Function, and Immune Homeostasis in COVID-19 Patients: The Role of Gut Microbiota in Immunity and Cancer Prevention

Systemic inflammation and immunological dysregulation are linked to COVID-19 infection, and there is mounting evidence that gut barrier failure and gut microbiota dysbiosis are related.  Gaining knowledge of these relationships could help explain how diseases develop.  By measuring biomarkers and cytokine levels, this research aims to analyze the relationships among gut microbiota alterations, gut barrier function, and immunological homeostasis in COVID-19 patients. Using IBM SPSS (version 26) with Pearson Correlation, Chi-Square testing, independent t-tests, and Multivariate Regression analysis, a comparative study was conducted using gut barrier biomarkers (Zonulin, LPS, I-FABP) and cytokine levels (IL-6, IL-10, TNF-α). In COVID-19 individuals, there were notable variations in gut barrier biomarkers and cytokine levels, with robust associations suggesting a connection between immune dysregulation and gut barrier failure. Gut microbiota dysbiosis and gut barrier dysfunction are significantly associated with immune homeostasis disturbance in COVID-19 patients, which may be a contributing factor to the disease's severity and progression.

• Publication year

  2025

• Venue

  Health Leadership and Quality of Life

• Publication date

  2025-08-04

• Fields of study

  Not labeled

• Identifiers
  DOI 10.56294/hl2025354
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Microbiota and Immunity during Respiratory Infections: Lung and Gut Affair

  2024cited by this paper
• Ongoing Treatment with a Spore-Based Probiotic Containing Five Strains of Bacillus Improves Outcomes of Mild COVID-19

  2023cited by this paper
• Alterations in Gut Microbiota Composition in Patients with COVID-19: A Pilot Study of Whole Hypervariable 16S rRNA Gene Sequencing

  2023cited by this paper
• SARS CoV-2-Induced Viral Sepsis: The Role of Gut Barrier Dysfunction

  2022cited by this paper
• Metagenomic assessment of gut microbial communities and risk of severe COVID-19

  2022cited by this paper
• COVID-19 and Gut Injury

  2022cited by this paper
• Possible role of gut microbes and host’s immune response in gut–lung homeostasis

  2022cited by this paper
• SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19

  2022cited by this paper
• Optimizing the Illumina COVIDSeq laboratorial and bioinformatics pipeline on thousands of samples for SARS-CoV-2 Variants of Concern tracking

  2022cited by this paper
• Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19

  2021cited by this paper
• The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

  2020cited by this paper
• The Microbiota/Host Immune System Interaction in the Nose to Protect from COVID-19

  2020cited by this paper
• Gut microbiota and Covid-19- possible link and implications

  2020cited by this paper
• Circulating levels of IL‐2, IL‐4, TNF‐α, IFN‐γ, and C‐reactive protein are not associated with severity of COVID‐19 symptoms

  2020cited by this paper
• Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19

  2020cited by this paper
• Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19

  2020cited by this paper
• Acupressure therapy and Liu Zi Jue Qigong for pulmonary function and quality of life in patients with severe novel coronavirus pneumonia (COVID-19): a study protocol for a randomized controlled trial

  2020cited by this paper
• Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives

  2020cited by this paper
• Global perspective of COVID‐19 epidemiology for a full‐cycle pandemic

  2020cited by this paper
• Intestinal Barrier Function in Health and Disease—Any Role of SARS-CoV-2?

  2020cited by this paper
• Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota

  2020cited by this paper

• No citing papers are available for this paper.